Public Board of Directors papers 27.01.22

In response to the recommendations of the review we can confirm that: Review of the FTSU Process • The BoD undertook a self-assessment using the NHSEI ‘Freedom to Speak Up review tool for NHS Trusts and Foundation Trusts’ at its November 2018 meeting. • Following updated national guidance the self-assessment was reviewed and a revised FTSU policy and action plan presented to the board in April 2020. • The FTSU policy and action plan was again refreshed and approved by the board of directors in April 2021. • An update on progress with the action plan was discussed by the BoD in October 2021. • Following discussion, including with the FTSUG, the Trust intends to maintain the current reporting line of the FTSUG. • The FTSU policy contains a flow chart and procedure for identifying the nature of concerns and appropriate escalation processes including how to seek advice and manage complex whistle-blowing cases. • The BoD has supported a recent programme of initiatives aimed at promoting a speaking up culture including, the appointment of FTSU Champions, FTSU Training and the Listen to Learn Event. Progress is reported at Trust board meetings and information is also available on HIVE (The Trust Intranet) and cascaded via Team Brief • The Director of Workforce, Non-Executive Director and Chair have all reinforced the commitment to speaking up through their statement of support which is available to staff via the Trust’s intranet pages. • The Chief Executive emphasises the importance of speaking up in his presentation at the regular Trust-wide staff inductions. • Board members have recorded individual messages in support of speaking up and can also be seen across the Trust on relevant literature and posters. • Board members have led presentations at our Grand Rounds and presentations at Management Board to continue the commitment and support to speaking up. • The Freedom to Speak up Guardian reports every six months to the BoD and to the Management Board. Raising Concerns • The Head of Engagement is working with the R&I division to plan a programme of organisational development activity. • Further work will be undertaken with the Board of Directors as part of the Freedom to Speak Up action plan to reinforce the commitment to speaking up. This will also include a development session for the Board. • The Trust Respect campaign continues to be implemented. Messages of zero tolerance are continually provided by members of the Board recent examples include at Grand Rounds and the EDI summit. Terms of Reference 3 - How the Trust handled allegations concerning the sharing of patient data with Roche through the Foundation Medicine (FM) programme and Flatiron in and around 2018-date. Including whether people that raised concerns suffered detriment as a result. The “Rapid Review” report confirms that work taking place to evaluate a potential major commercial partnership was still at the exploratory pilot stage when it was paused due to concerns raised to the Executive Team by clinicians - no business case had been approved, and no contract had been signed. The report makes no reference to the question about detriment. In response to the concerns The Trust commissioned a review and audit by Professor Andrew Hughes to learn any lessons from this experience and has reflected on and built these into policies for future programmes. As a large research centre, The Christie has many collaborations with industry partners and shares data frequently in line with all legal and regulatory requirements and with appropriate regard to consent requirements. Databases including biobanks containing clinical

20